Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

FIBROGEN INC (FGEN) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 4 Schoeneck James A (Director) has filed a Form 4 on FIBROGEN INC
Txns: Granted 10,000 options to buy @ $1.44, valued at $14.4k
08/09/2023 4 Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC
Txns: Granted 200,000 shares @ $0
Granted 300,000 options to buy @ $1.77, valued at $531k
08/08/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/07/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/07/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/07/2023 8-K Quarterly results
Docs: "FibroGen Reports Second Quarter 2023 Financial Results • Topline data from three late-stage pamrevlumab trials expected through 1H 2024, including the Pancreatic Cancer Action Network Precision PromiseSM Phase 2/3 study in metastatic pancreatic cancer • Robust roxadustat volume growth of over 40% in China • Entered into exclusive license for FOR46, a first-in-class CD46-targeting antibody-drug conjugate for the treatment of metastatic castration-resistant prostate cancer • Implemented cost reduction plan extending cash runway into 2026 • Thane Wettig appointed Interim CEO"
08/04/2023 144 Form 144 - Report of proposed sale of securities:
07/25/2023 8-K Quarterly results
07/19/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/19/2023 8-K Quarterly results
07/13/2023 4 Henderson Jeffrey William (Director) has filed a Form 4 on FIBROGEN INC
Txns: Sold 2,000 shares @ $2.69, valued at $5.4k
07/11/2023 144 Form 144 - Report of proposed sale of securities:
07/10/2023 4 Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC
Txns: Sold 1,880 shares @ $2.8, valued at $5.3k
06/15/2023 4 Chung Christine (SVP, China Operations) has filed a Form 4 on FIBROGEN INC
Txns: Sold 6,250 shares @ $17.6, valued at $110k
Sold 5,250 shares @ $16.66, valued at $87.5k
Sold 1,000 shares @ $17.46, valued at $17.5k
06/09/2023 144 Form 144 - Report of proposed sale of securities:
06/09/2023 144 Form 144 - Report of proposed sale of securities:
06/09/2023 144 Form 144 - Report of proposed sale of securities:
06/09/2023 144 Form 144 - Report of proposed sale of securities:
06/09/2023 4 Cravatt Benjamin (Director) has filed a Form 4 on FIBROGEN INC
Txns: Granted 8,289 shares @ $0
Sold 1,766 shares @ $16.75, valued at $29.6k
Sold 2,178 shares @ $17.51, valued at $38.1k
Granted 12,666 options to buy @ $17.13, valued at $217k
06/09/2023 4 Brennan Aoife (Director) has filed a Form 4 on FIBROGEN INC
Txns: Granted 8,289 shares @ $0
Sold 1,994 shares @ $16.74, valued at $33.4k
Sold 2,739 shares @ $17.52, valued at $48k
Granted 12,666 options to buy @ $17.13, valued at $217k
06/09/2023 4 Blaug Suzanne (Director) has filed a Form 4 on FIBROGEN INC
Txns: Granted 8,289 shares @ $0
Sold 3,351 shares @ $16.73, valued at $56.1k
Sold 5,169 shares @ $17.51, valued at $90.5k
Granted 12,666 options to buy @ $17.13, valued at $217k
06/09/2023 4 Ho Maykin (Director) has filed a Form 4 on FIBROGEN INC
Txns: Granted 8,289 shares @ $0
Sold 2,295 shares @ $16.79, valued at $38.5k
Sold 6,225 shares @ $17.68, valued at $110.1k
Granted 12,666 options to buy @ $17.13, valued at $217k
06/09/2023 4 Lema Gerald (Director) has filed a Form 4 on FIBROGEN INC
Txns: Granted 8,289 shares @ $0
Granted 12,666 options to buy @ $17.13, valued at $217k
06/09/2023 4 EDWARDS JEFFREY L (Director) has filed a Form 4 on FIBROGEN INC
Txns: Granted 8,289 shares @ $0
Sold 3,265 shares @ $16.74, valued at $54.7k
Sold 4,624 shares @ $17.51, valued at $81k
Granted 12,666 options to buy @ $17.13, valued at $217k
06/09/2023 4 Henderson Jeffrey William (Director) has filed a Form 4 on FIBROGEN INC
Txns: Granted 8,289 shares @ $0
Sold 2,006 shares @ $16.87, valued at $33.8k
Sold 4,994 shares @ $17.69, valued at $88.3k
Granted 12,666 options to buy @ $17.13, valued at $217k
06/09/2023 4 Schoeneck James A (Director) has filed a Form 4 on FIBROGEN INC
Txns: Granted 8,289 shares @ $0
Sold 7,100 shares @ $18.0264, valued at $128k
Granted 12,666 options to buy @ $17.13, valued at $217k
06/09/2023 4 Wettig Thane (Chief Commercial Officer) has filed a Form 4 on FIBROGEN INC
Txns: Sold 472 shares @ $17.0356, valued at $8k
Sold 1,286 shares @ $17.0377, valued at $21.9k
06/09/2023 4 Graham Juan (CFO) has filed a Form 4 on FIBROGEN INC
Txns: Sold 1,050 shares @ $16.9494, valued at $17.8k
Sold 735 shares @ $17.0383, valued at $12.5k
06/09/2023 4 Chung Christine (SVP, China Operations) has filed a Form 4 on FIBROGEN INC
Txns: Sold 1,362 shares @ $17.0353, valued at $23.2k
Sold 739 shares @ $17.0363, valued at $12.6k
Sold 1,532 shares @ $17.0376, valued at $26.1k
06/09/2023 4 Eisner Mark (EVP, Chief Medical Officer) has filed a Form 4 on FIBROGEN INC
Txns: Sold 2,042 shares @ $17.038, valued at $34.8k
06/09/2023 4 Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC
Txns: Sold 2,791 shares @ $17.0368, valued at $47.5k
Sold 6,106 shares @ $17.0379, valued at $104k
06/09/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
06/08/2023 144 Form 144 - Report of proposed sale of securities:
06/08/2023 144 Form 144 - Report of proposed sale of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy